| Date | Time | Source | Headline | Symbol | Company |
| 18/07/2013 | 20:30 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 20:30 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 20:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 20:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 20:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 20:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 20:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 19:58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 19:57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 19:56 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 19:55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 19:53 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 19:52 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 19:50 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 18:49 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 18:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 18:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 18:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 18:47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 18:47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 18:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 18/07/2013 | 16:39 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 16/07/2013 | 18:43 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 16/07/2013 | 17:00 | PR Newswire (US) | Omthera Stockholders Approve Acquisition by AstraZeneca | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 11/07/2013 | 14:13 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 10/07/2013 | 22:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 09/07/2013 | 14:59 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 09/07/2013 | 14:59 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 09/07/2013 | 11:00 | PR Newswire (US) | Omthera Pharmaceuticals Announces NDA Submission for Epanova™ for the Treatment of Patients with Very High Triglycerides | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |
| 27/06/2013 | 16:54 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:OMTH | Omthera Pharmaceuticals, Inc. (MM) |